Wellington Shields Capital Management, LLC Abbott Laboratories Transaction History

Wellington Shields Capital Management, LLC

$567 Million
Q2 2025

A detailed history of Wellington Shields Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wellington Shields Capital Management, LLC holds 12,709 shares of ABT stock, worth $1.67 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

12,709

Previous 12,709 -0.0%

Holding current value

$1.67 Million

Previous $1.69 Million 2.55%

% of portfolio

0.3%

Previous 0.31%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$111.1 - $140.22 $13,665 - $17,247	123 Added 0.98%	12,709 $1.69 Million
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $600,420 - $708,780	-6,000 Reduced 32.28%	12,586 $1.43 Million
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $12,389 - $13,830	-123 Reduced 0.66%	18,586 $1.93 Million
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $60,236 - $66,528	-550 Reduced 2.86%	18,709 $2.13 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $4,238 - $5,188	-47 Reduced 0.24%	19,259 $2.12 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $52,541 - $63,041	550 Added 2.93%	19,306 $1.87 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $11,892 - $13,250	-118 Reduced 0.63%	18,756 $2.04 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $222,778 - $262,223	-2,300 Reduced 10.86%	18,874 $1.91 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $171,108 - $200,736	1,800 Added 9.29%	21,174 $2.33 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $967 - $1,120	-10 Reduced 0.05%	19,374 $1.88 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $43,992 - $53,172	-431 Reduced 2.18%	19,384 $2.11 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $980,572 - $1.2 Million	-8,600 Reduced 30.27%	19,815 $2.35 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $5,660 - $6,931	49 Added 0.17%	28,415 $4 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $24,031 - $26,586	-206 Reduced 0.72%	28,366 $3.35 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $4,654 - $5,479	-44 Reduced 0.15%	28,572 $3.31 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $4,462 - $5,257	-41 Reduced 0.14%	28,616 $3.43 Million
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $75,694 - $91,925	-826 Reduced 2.8%	28,657 $3.12 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $82,465 - $105,546	1,077 Added 3.79%	29,483 $2.7 Million
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $11,810 - $17,269	188 Added 0.67%	28,406 $2.24 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $119,196 - $144,108	-1,800 Reduced 6.0%	28,218 $2.26 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $1.44 Million - $1.61 Million	30,018	30,018 $1.6 Million

Others Institutions Holding ABT

# of Institutions

3,580

Shares Held

1.39B

Call Options Held

9.32M

Put Options Held

8.78M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.

Account

Wellington Shields Capital Management, LLC Abbott Laboratories Transaction History